These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 20948523

  • 1. Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI.
    Lambrinoudaki I, Armeni E, Rizos D, Deligeoroglou E, Kofinakos P, Kaparos G, Alexandrou A, Creatsa M, Logothetis E, Kouskouni E.
    Obesity (Silver Spring); 2011 May; 19(5):988-93. PubMed ID: 20948523
    [Abstract] [Full Text] [Related]

  • 2. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 11; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 4. Relation of BMI and physical activity to sex hormones in postmenopausal women.
    McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY, Women's Health Initiative Investigators.
    Obesity (Silver Spring); 2006 Sep 11; 14(9):1662-77. PubMed ID: 17030978
    [Abstract] [Full Text] [Related]

  • 5. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar 11; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 6. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
    Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, Buring JE.
    Circulation; 2003 Oct 07; 108(14):1688-93. PubMed ID: 12975257
    [Abstract] [Full Text] [Related]

  • 7. Endogenous sex steroids and circulating homocysteine in healthy Greek postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Rizos DA, Alexandrou A, Kountouris AV, Creatsas GC.
    Hormones (Athens); 2006 Oct 07; 5(1):35-41. PubMed ID: 16728383
    [Abstract] [Full Text] [Related]

  • 8. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years.
    Jiroutek MR, Chen MH, Johnston CC, Longcope C.
    Menopause; 1998 Oct 07; 5(2):90-4. PubMed ID: 9689202
    [Abstract] [Full Text] [Related]

  • 9. The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women.
    Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A.
    Acta Obstet Gynecol Scand; 1999 Aug 07; 78(7):642-7. PubMed ID: 10422913
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J, Klaiber E, Wiita B, Bowen A, Yang HM.
    Menopause; 1999 Aug 07; 6(2):138-46. PubMed ID: 10374221
    [Abstract] [Full Text] [Related]

  • 11. Associations of endogenous sex hormones and sex hormone-binding globulin with lipid profiles in aged Japanese men and women.
    Yasui T, Uemura H, Irahara M, Arai M, Kojimahara N, Okabe R, Ishii Y, Tashiro S, Sato H.
    Clin Chim Acta; 2008 Dec 07; 398(1-2):43-7. PubMed ID: 18755173
    [Abstract] [Full Text] [Related]

  • 12. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 13. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
    Randolph JF, Sowers M, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, Brockwell SE, Matthews KA.
    J Clin Endocrinol Metab; 2005 Nov 20; 90(11):6106-12. PubMed ID: 16144949
    [Abstract] [Full Text] [Related]

  • 14. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.
    Maturitas; 2008 Jan 20; 59(1):62-71. PubMed ID: 18164562
    [Abstract] [Full Text] [Related]

  • 15. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 Jan 20; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 16. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
    Sowers MR, Finkelstein JS, Ettinger B, Bondarenko I, Neer RM, Cauley JA, Sherman S, Greendale GA, Study of Women's Health Across the Nation.
    Osteoporos Int; 2003 Jan 20; 14(1):44-52. PubMed ID: 12577184
    [Abstract] [Full Text] [Related]

  • 17. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L.
    Maturitas; 1995 Feb 20; 21(2):103-13. PubMed ID: 7752947
    [Abstract] [Full Text] [Related]

  • 18. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M, Carlström K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B.
    Gynecol Endocrinol; 2005 Feb 20; 20(2):110-5. PubMed ID: 15823831
    [Abstract] [Full Text] [Related]

  • 19. Correlation of Kupperman's index with estrogen and androgen levels, according to weight and body fat distribution in postmenopausal women from Mexico City.
    Carranza-Lira S, Velasco Díaz G, Olivares A, Chán Verdugo R, Herrera J.
    Int J Fertil Womens Med; 2006 Feb 20; 51(2):83-8. PubMed ID: 16881384
    [Abstract] [Full Text] [Related]

  • 20. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005 Feb 20; 56(6):883-90. PubMed ID: 16821206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.